Trends in Medical Encounters Involving Cannabis-Related Disorders Among US Medicare Beneficiaries, 2017–2022
American Journal of Public Health · 2024
DOI: 10.2105/ajph.2024.307729 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Public Health, 2024. Verfasst von Silvia Perez-Vilar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Silvia Perez-Vilar, Christina Greene, Rose Radin, and David J. Graham are with the Center for Drug Evaluation and Research, US Food and Drug Administ…. Hauptthemen laut MEDLINE: Medicare, Marijuana Abuse. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
To characterize cannabis-related disorder medical encounter trends in the US Medicare population during 2017 to 2022.
Methods
We conducted a descriptive study, which included 56 624 432 beneficiaries aged 65 years or older and 10 247 953 aged 18 to 64 years with disability. All were continuously enrolled in Medicare (Fee-for-Service or Advantage) for 183 or more days before the first day of the calendar year. We identified cannabis-related disorder encounters using International Classification of Diseases, 10th Revision, Clinical Modification diagnosis codes and computed annual encounter rates per 10 000 beneficiaries. We used the Mann–Kendall test to analyze trends over time.
Results
Annual cannabis-related disorder encounter trends among beneficiaries aged 65 years or older ranged from 15.9 (95% confidence interval [CI] = 15.8, 16.0) to 39.3 (95% CI = 39.1, 39.5) per 10 000. Rates among beneficiaries aged 18 to 64 years with disability ranged from 274.8 (95% CI = 273.6, 276.0) to 373.7 (95% CI = 372.3, 375.2) per 10 000. Rates increased over time across both groups, with average annual increases of 4.3 (95% CI = 3.3, 5.3; P = .01) and 17.1 (95% CI = 11.0, 23.2; P = .02) per 10 000, respectively.
Conclusions
Further work is needed to explore the impact of coexisting medical conditions on outcomes that result from cannabis-related disorders. ( Am J Public Health. 2024;114(S8):S694–S697. https://doi.org/10.2105/AJPH.2024.307729 )
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Silvia Perez-Vilar, Christina Greene, Rose Radin, and David J. Graham are with the Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD. Sara Kazemian was with Acumen LLC, Burlinga…
ORCID-Profile: Silvia Perez-Vilar, Rose Radin, Michael Wernecke, David J Graham
Zitieren
APA
Perez-Vilar, S., Kazemian, S., Greene, C., Duenas, P. F., Radin, R., Lindaas, A., Akhtar, S., Wernecke, M., Chillarige, Y., Kelman, J. A., & Graham, D. J. (2024). Trends in Medical Encounters Involving Cannabis-Related Disorders Among US Medicare Beneficiaries, 2017–2022. American Journal of Public Health. https://doi.org/10.2105/ajph.2024.307729
Vancouver
Perez-Vilar S, Kazemian S, Greene C, Duenas PF, Radin R, Lindaas A, et al. Trends in Medical Encounters Involving Cannabis-Related Disorders Among US Medicare Beneficiaries, 2017–2022. American Journal of Public Health. 2024. doi:10.2105/ajph.2024.307729
BibTeX
@article{PerezVilar2024,
author = {Perez-Vilar, Silvia and Kazemian, Sara and Greene, Christina and Duenas, Pablo Freyria and Radin, Rose and Lindaas, Arnstein and Akhtar, Sandia and Wernecke, Michael and Chillarige, Yoganand and Kelman, Jeffrey A and Graham, David J},
title = {Trends in Medical Encounters Involving Cannabis-Related Disorders Among US Medicare Beneficiaries, 2017–2022},
journal = {American Journal of Public Health},
year = {2024},
doi = {10.2105/ajph.2024.307729}
}
EUVIMED